Evidence Hub

Management of male premature ejaculation: from past to future

Chang J, Zhao W, Ma L, Zhao J, Li Q, Wang X, Ju H, Wang X et al.

Frontiers in endocrinology, 2025

1 citation

Abstract

Premature ejaculation (PE) is a common disease of the male reproductive system, which seriously affects the quality of life of patients and their partners. Currently, PE is regarded as a biopsychosocial disease with complex etiologies and diverse treatment methods. Oral selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for PE, with advantages such as high safety, rapid onset of action, and non-invasiveness. However, topical anesthetics, behavioral and psychological therapies, device-assisted treatments, and traditional Chinese medicine (TCM) can also serve as alternative therapies for patients intolerant to SSRIs. With the rapid development of technology, some new methods-such as low-intensity extracorporeal shock wave therapy (Li-ESWT) and transcutaneous electrical nerve stimulation (TENS)-can even improve PE through mechanisms like regulating nerve conduction and improving local microcirculation. These are all important directions for the future treatment of male PE. In this mini-review, we will elaborate on these therapeutic approaches.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free